179 related articles for article (PubMed ID: 9070487)
1. Activation of the K-ras oncogene in colorectal neoplasms is associated with decreased apoptosis.
Ward RL; Todd AV; Santiago F; O'Connor T; Hawkins NJ
Cancer; 1997 Mar; 79(6):1106-13. PubMed ID: 9070487
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR
Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045
[TBL] [Abstract][Full Text] [Related]
4. Laterally spreading type of colorectal adenoma exhibits a unique methylation phenotype and K-ras mutations.
Hiraoka S; Kato J; Tatsukawa M; Harada K; Fujita H; Morikawa T; Shiraha H; Shiratori Y
Gastroenterology; 2006 Aug; 131(2):379-89. PubMed ID: 16890591
[TBL] [Abstract][Full Text] [Related]
5. Natural history of colorectal nonpolypoid adenomas: a prospective colonoscopic study and relation with cell kinetics and K-ras mutations.
Watari J; Saitoh Y; Obara T; Fujiya M; Maemoto A; Ayabe T; Ashida T; Yokota K; Orii Y; Kohgo Y
Am J Gastroenterol; 2002 Aug; 97(8):2109-15. PubMed ID: 12190185
[TBL] [Abstract][Full Text] [Related]
6. CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation.
Kim H; Yang XL; Rosada C; Hamilton SR; August JT
Arch Biochem Biophys; 1994 May; 310(2):504-7. PubMed ID: 7513984
[TBL] [Abstract][Full Text] [Related]
7. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
8. Relationship between cyclooxygenase-2 expression and K-ras gene mutation in colorectal adenomas.
Fujita M; Fukui H; Kusaka T; Morita K; Fujii S; Ueda Y; Chiba T; Sakamoto C; Kawamata H; Fujimori T
J Gastroenterol Hepatol; 2000 Nov; 15(11):1277-81. PubMed ID: 11129221
[TBL] [Abstract][Full Text] [Related]
9. Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of vater.
Matsubayashi H; Watanabe H; Yamaguchi T; Ajioka Y; Nishikura K; Kijima H; Saito T
Cancer; 1999 Aug; 86(4):596-607. PubMed ID: 10440687
[TBL] [Abstract][Full Text] [Related]
10. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.
Zhu D; Keohavong P; Finkelstein SD; Swalsky P; Bakker A; Weissfeld J; Srivastava S; Whiteside TL
Cancer Res; 1997 Jun; 57(12):2485-92. PubMed ID: 9192830
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
12. [Expression of p53 and bcl-2 in colorectal adenomas and carcinomas].
Sundblad AS; Chumbita RL; Zoppi JA
Medicina (B Aires); 1997; 57(6):662-6. PubMed ID: 9674186
[TBL] [Abstract][Full Text] [Related]
13. Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas.
Minamoto T; Sawaguchi K; Mai M; Yamashita N; Sugimura T; Esumi H
Cancer Res; 1994 Jun; 54(11):2841-4. PubMed ID: 8187064
[TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum.
Mosnier JF; Perret AG; Vindimian M; Dumollard JM; Balique JG; Perpoint B; Boucheron S
Arch Pathol Lab Med; 1996 Jul; 120(7):654-9. PubMed ID: 8757470
[TBL] [Abstract][Full Text] [Related]
15. K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis.
Chaubert P; Benhattar J; Saraga E; Costa J
Am J Pathol; 1994 Apr; 144(4):767-75. PubMed ID: 8160776
[TBL] [Abstract][Full Text] [Related]
16. [Cell kinetics of colorectal tumors with assessment by K-ras mutation and PCNA labeling index].
Tanaka M; Omura K; Ishida F; Watanabe Y
Nihon Geka Gakkai Zasshi; 1993 Dec; 94(12):1249-55. PubMed ID: 7903793
[TBL] [Abstract][Full Text] [Related]
17. Molecular changes in the Ki-ras and APC genes in colorectal adenomas and carcinomas arising in the same patient.
Zauber NP; Sabbath-Solitare M; Marotta SP; Zauber AG; Bishop DT
J Pathol; 2001 Mar; 193(3):303-9. PubMed ID: 11241408
[TBL] [Abstract][Full Text] [Related]
18. High-degree tumor budding and podia-formation in sporadic colorectal carcinomas with K-ras gene mutations.
Prall F; Ostwald C
Hum Pathol; 2007 Nov; 38(11):1696-702. PubMed ID: 17707462
[TBL] [Abstract][Full Text] [Related]
19. Programmed cell death in colorectal carcinogenesis.
Valentini AM; Caruso ML; Armentano R; Pirrelli M; Rizzi E; Lapenna F; Renna L
Anticancer Res; 1999; 19(4B):3019-24. PubMed ID: 10652586
[TBL] [Abstract][Full Text] [Related]
20. Loss of p21WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers.
Sinicrope FA; Roddey G; Lemoine M; Ruan S; Stephens LC; Frazier ML; Shen Y; Zhang W
Clin Cancer Res; 1998 May; 4(5):1251-61. PubMed ID: 9607584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]